$EPC

Edgewell Personal Care Announces Third Quarter Fiscal 2026 Results

Edgewell Personal Care (NYSE: EPC) reported fiscal 2026 third-quarter results ended June 30, 2026. Net sales rose 1.7% to $570.1M, with organic sales up 1.1%. Adjusted EPS was $0.72, flat year over year, while GAAP diluted EPS was $0.26. The company said full-year outlook was narrowed, with adjusted EPS and EBITDA midpoints unchanged, and declared a $0.15 dividend.

Original reporting
Published Aug 5, 2026, 10:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 11:14 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Edgewell Personal Care Announces Third Quarter Fiscal 2026 Results — source image
Decision brief

The 30-second read

$EPCNeutralMed
01

Why it matters

Traders can update expectations for FY2026 trajectory based on 3Q organic sales returning to growth, North America improving meaningfully, and adjusted EPS/EBITDA beating expectations, while monitoring margin compression and restructuring costs.

02

Market read

A company-specific earnings release with quantified sales, EPS, margin, cash, leverage, and capital allocation details, plus a narrowed full-year outlook (midpoints unchanged).

03

What to watch

International organic sales decline cites temporary disruption and Wet Shave manufacturing consolidation; if these effects persist longer than expected, the back-half growth narrative could weaken despite the narrowed outlook.

Relevance 7/10Novelty 7/10Timing: pre-market today (Aug. 5, 2026) earnings release

Background

Edgewell’s release excludes the Feminine Care business as discontinued operations and reports both GAAP and non-GAAP metrics, with a stated back-half story for FY2026.

Company-level read

Ticker impact

$EPCNeutralMedium confidence
Context

Edgewell reported 3Q FY2026 net sales of $570.1M (+1.7% YoY) and adjusted EPS of $0.72, with North America organic sales up 3.0%.

Expected impact

Likely choppy reaction: upside from organic growth and EPS/EBITDA ahead of expectations, offset by margin compression and GAAP EPS decline.

Evidence & confidence

The release provides multiple directional datapoints (organic growth, North America improvement, adjusted EPS flat YoY, gross margin down 210 bps, adjusted operating income down as a % of sales) but does not include the specific full-year outlook numbers, limiting precision on valuation impact.

Market effects

Personal care peers may see read-across on demand stability and margin pressure drivers (tariffs, mix, promotions) versus productivity savings.

North America improvement versus international softness highlights regional divergence that could influence sector positioning.

International weakness tied to Middle East conflict and supply chain disruption reinforces ongoing geopolitical and logistics sensitivity for consumer staples/personal care supply chains.

Counterpoint

North America growth may be execution-driven but not translating into stronger profitability, as gross margin and adjusted operating income as a % of sales both declined.

Key entities

  • Edgewell Personal Care Company

    Reported 3Q FY2026 results, including organic net sales growth, North America improvement, margin changes, restructuring costs, and a declared quarterly dividend.

  • Rod Little

    CEO who stated the company remains on track for a back-half weighted FY2026 progression and is increasingly confident in the business trajectory.

Related articles

$EPCMedAI 8/10

Edgewell Personal Care Q3 Earnings Call Highlights

Edgewell Personal Care (EPC) reported Q3 organic sales trends: wet shave organic sales fell 1.9% as private-label supply disruptions outweighed branded growth, while U.S. razors and blades consumption rose with higher promotions. Sun and skin care organic sales rose 5%. Adjusted operating income was $53M (9.3% margin); GAAP EPS $0.26 vs $0.46. Fiscal 2026 adjusted EPS guidance is $1.80-$2.00.

$EPCMed

EDGEWELL PERSONAL CARE Co (EPC): Results of Operations and Financial Condition

EDGEWELL PERSONAL CARE Co (EPC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q3fy26-epcexhibit991.htm EX-99.1 Document Exhibit 99.1 Edgewell Personal Care Company 6 Research Drive Shelton, Conn 06484 FOR IMMEDIATE RELEASE Company Contact Chris Gough Vice President, Investor Relations 203-944-5706 Chris.Gough@Edgewell.com Edgewell Personal Care A

$EPCMedAI 8/10

Why Is Edgewell Personal Care (EPC) Stock Soaring Today

Edgewell Personal Care (EPC) shares rose 13.7% in the afternoon after the company rejected an unsolicited takeover offer from private equity firm Yellow Wood Partners, priced at $30 per share, according to reports. The board reportedly viewed the bid as too low. The stock is up 55.6% year-to-date and trades near its 52-week high.

$MUMed

Stocks making the biggest moves midday: Micron Technology, SpaceX, IBM, Flex & more

Midday movers: Micron fell over 10% amid a broader tech selloff; Marvell slid 8% and Sandisk dropped 11%. Accenture rose nearly 2% after raising its buyback by $2B to over $7B. Flex fell over 2% after COO sold 36,000 shares. IBM gained over 4% after a JPMorgan overweight upgrade. Carnival dropped 6% on weaker Q3 guidance. AMC sank 25% on a planned 95.3M-share sale.

$USNAHighAI 9/10

Why Usana Health Sciences Stock Plummeted This Week

Usana Health Sciences (USNA) shares fell about 30% after its Aug. 4 Q2 results missed expectations and guidance disappointed. The company reported non-GAAP EPS of $0.07 on about $223M sales, with sales and profit below analyst averages. It also took a $29M goodwill impairment on Hiya, cut 2024 guidance to an $11M loss and lowered sales to $910M from $925M-$1B.

$WTIMed

W&T Offshore Q2 Earnings Call Highlights

W&T Offshore (WTI) reported Q2 realized oil-equivalent prices of $50.23/bbl, up 11% from Q1 and about 40% vs year-end 2025. It forecast Q3 production above 35,000 boe/d midpoint. Q2 LOE was $72M and capex $10.4M. Full-year 2026 capex guidance is $20M-$25M. Management discussed surety litigation and potential damages.